My HPRA: Register

IPRAMOL STERI-NEB

0.5/2.5 mg/mg Nebuliser Solution

Norton Healthcare Limited T/A IVAX Pharmaceuticals UKPA0282/079/001

Main Information

Trade NameIPRAMOL STERI-NEB
Active SubstancesIPRATROPIUM BROMIDE MONOHYDRATE
SALBUTAMOL SULFATE
Strength0.5/2.5 mg/mg
Dosage FormNebuliser Solution
Licence HolderNorton Healthcare Limited T/A IVAX Pharmaceuticals UK
Licence NumberPA0282/079/001

Group Information

ATC CodeR03AL02 Adrenergics in combination with anticholinergics

Status

Authorised/WithdrawnAuthorised
Licence Issued15/04/2005
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.